FY2025 EPS Estimates for Surmodics Boosted by Zacks Research
Surmodics, Inc. (NASDAQ:SRDX – Free Report) – Equities researchers at Zacks Research increased their FY2025 earnings per share estimates for shares of Surmodics in a research report issued on Thursday, February 27th. Zacks Research analyst D. Dey now anticipates that the company will post earnings per share of $0.19 for the year, up from their […]
